NEUROGENE INC.

ACTIVE

10301 Stella Link Rd Ste C, 华盛顿州金郡, 华盛顿州, United Stateswww.neoleukin.comPrivate56 employeesEstablished: 2003-12-01

Also known as:

nltx

Neoleukin Therapeutics, Inc.

Part of Neurogene, Inc.

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2003

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

33.3%

Phase 3

16.7%

Trial Status Distribution

Active, not recruiting

33.3%

Completed

33.3%

Terminated

33.3%

Clinical Trials

Trials sponsored by this organization (6)

A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome

Phase 3

Active, not recruiting

interventional

Jun 202333 participants

Gene Therapy Study for Children With CLN5 Batten Disease

Phase 1

Active, not recruiting

interventional

Jan 20226 participants

NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer

Phase 1

Completed

interventional

Apr 202159 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations

NEUROGENE INC.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (6)

A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome

Gene Therapy Study for Children With CLN5 Batten Disease

NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer

A Natural History Study of Charcot-Marie-Tooth 4J (CMT4J)

A Natural History Study of Aspartylglucosaminuria

A Natural History Study of Neuronal Ceroid Lipofuscinosis Type 5 (CLN5)

Approvals

News